PubMed Health⌕ Search

PubMed · 16830005

SARS revisited: managing "outbreaks" with "communications".

Abstract

"Risk communications" has acquired some importance in the wake of our experience of SARS. Handled well, it helps to build mutual respect between a government or an organisation and the target groups with which it is communicating. It helps nurture public trust and confidence in getting over the crisis. The World Health Organization (WHO) has also come to recognise its importance after SARS and organised the first Expert Consultation on Outbreak Communications conference in Singapore in September 2004. This article assesses the context and the key features which worked to Singapore's advantage. Looking at the data now widely available on the Internet of the experience of SARS-infected countries like China, Taiwan, Canada, the article identifies the key areas of strategic communications in which Singapore fared particularly well. Another issue discussed is whether Singapore's experience has universal applicability or whether it is limited because of Singapore's unique cultural, historical and geographical circumstances. Finally, the article also looks at some of the post-SARS enhancements that have been put in place following the lessons learnt from SARS and the need to confront new infectious outbreaks like avian flu.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K U Menon. 2006. SARS revisited: managing "outbreaks" with "communications".. https://pubmed.ncbi.nlm.nih.gov/16830005/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

On-demand therapy for gastroesophageal reflux disease.

The following pages summarize the proceedings of a symposium held in May 2006 on the emerging role of on-demand therapy for gastroesophageal reflux disease (GERD). Medical therapy for GERD has undergone significant change in recent years with the advent of effective, but expensive, antisecretory agents. On-demand (patient-driven) therapy is attractive to payers and patients, because it appears to be both cost-effective and convenient. Many individuals appear to accept occasional symptomatic breakthrough in exchange for personal control of their disease. On-demand therapy should be distinguished from intermittent therapy, which is either patient- or physician-driven, but which requires intermittent episodes of continuous therapy followed by discontinuation until symptoms recur. Proton pump inhibitors appear to be effective on-demand agents despite theoretical pharmacodynamic limitations for this class of drug. The available data support the use of on-demand therapy for GERD in uninvestigated reflux disease, nonerosive reflux disease, and possibly mild esophagitis as well. On-demand therapy should not be considered for patients with severe esophagitis.

Congresses as Topic↗